Molecular Pathology of Giant Axonal Neuropathy Demystified
One of the rare genetic disorders, giant axonal neuropathy (GAN) causes central and peripheral nervous system dysfunction.
One of the rare genetic disorders, giant axonal neuropathy (GAN) causes central and peripheral nervous system dysfunction.
‘The Association for Molecular Pathology (AMP) has updated its pathology residency curriculum recommendations for 10 critical molecular pathology topics.’
Tweet it Now
Developed by a task force of the AMP Training and Education Committee, the latest report is intended to be an update to the original curriculum guidance published by the committee in 1999. The paper provides residency programs with specific recommendations from subject matter experts on 10 major molecular pathology topics: basic molecular pathology goals and laboratory management; basic concepts in molecular biology and genetics; technology; inherited disorders; oncology; infectious diseases; pharmacogenetics; histocompatibility and identity; genomics, and information management. Charles E. Hill, AMP President and corresponding author of the paper, said, "Molecular pathology is a rapidly evolving area that has the potential to revolutionize the way healthcare is delivered and, as a result, has become an essential and growing component of pathology residency programs. As the voice of molecular diagnostics professionals, AMP remains committed to ensuring medical schools and residency programs are able to incorporate the latest scientific breakthroughs and technological innovations in molecular pathology. This report is another great example of how we are bringing together the subject matter experts to address today’s key issues so that pathologists are better equipped to handle the cases tomorrow."
Source-Eurekalert
Researcher Seeks Source of Body Louse Pathology
Study seeks to determine how one parasitic species can give rise to two drastically different outcomes in its host.
Study seeks to determine how one parasitic species can give rise to two drastically different outcomes in its host.
ProMark Accurately Predicts Aggressive Prostate Cancer, Pathology Outcomes
Metamark has for the first time, presented results the clinical validation study that showed ProMark™, the first proteomic-based imaging biopsy test
Metamark has for the first time, presented results the clinical validation study that showed ProMark™, the first proteomic-based imaging biopsy test
Results of Fingerprick Blood Tests can Vary from Drop to Drop of Sample
Results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.
Results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.
